logo

NSPR

InspireMD·NASDAQ
--
--(--)
--
--(--)
1.10 / 10
Underperform

NSPR's fundamentals are subpar, scoring only 1.1/10. Key weaknesses include negative asset-to-market value (-0.5007) and revenue-to-market value (-1.7637) differences, both in the first performance group with historically poor returns. Net income-to-revenue (-0.1668) is also weak, while cash-related metrics show limited improvement. The stock's ROA (-59.11%) and net profit margin on assets (-78.81%) are deeply negative, reinforcing the underperform label.

Fundamental(1.1)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-1.76
Score2/3
Weight-0.29%
1M Return0.09%
ROA (%)
Value-59.11
Score0/3
Weight16.56%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-78.81
Score0/3
Weight16.56%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Cash-MV
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Is NSPR undervalued or overvalued?
  • NSPR scores 1.10/10 on fundamentals and holds a Premium valuation at present. Backed by its -73.90% ROE, -593.89% net margin, -1.57 P/E ratio, 1.13 P/B ratio, and -15.49% earnings growth, these metrics solidify its Underperform investment rating.